Tetra Bio-Pharma Inc. Receives Notice of Authorization from Health Canada for the Conduct of its Clinical Trial with its PPTGR ...
OTTAWA, ONTARIO--(Marketwired - Feb 1, 2017) - PhytoPain Pharma Inc. ("PPP"), a subsidiary of Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (CSE:TBP), a pharmaceutical company focused on developing and commercializing …